Journal: Molecular and Cellular Biology
Article Title: Insulin Inhibits Lipolysis in Adipocytes via the Evolutionarily Conserved mTORC1-Egr1-ATGL-Mediated Pathway
doi: 10.1128/MCB.01584-12
Figure Lengend Snippet: Egr1 suppresses ATGL promoter activity. 293T cells were transfected with different lengths of mouse ATGL luciferase promoter constructs, together with eGFP. Cells were cotransfected with either Egr1 cDNA (A), Egr2 cDNA (B), or empty vector (EV). The luciferase activity in cell lysates was assayed as described in Materials and Methods and normalized based on the GFP fluorescence. Experiments were repeated three times, and data are presented for triplicate samples as means ± the SD. (C) Schematic representation of the proximal region of ATGL promoter with the consensus Egr1 binding site. Nucleotides that have been chosen for the site-directed mutagenesis are underlined. (D) Conserved nucleotides −44, −42, −41, −40, and −36 in the ATGL promoter (underlined in panel C) were substituted by T's as described in Materials and Methods. HEK293T cells were transfected with wild-type (wt) or mutant (mt) ATGL luciferase promoter constructs, together with eGFP. Cells were cotransfected with Egr1 or Egr2 or empty vector (EV) and analyzed as described for panels A and B. (E) Wild-type and TSC2−/− MEFs were treated with 100 nM rapamycin (Rap) for 48 h. Total cell lysates were analyzed by Western blotting for Egr1. Actin served as a loading control. *, P < 0.05; **, P < 0.01 (all panels).
Article Snippet: Polyclonal antibody against Egr1 (sc110) was from Santa Cruz Biotechnology (Santa Cruz, CA).
Techniques: Activity Assay, Transfection, Luciferase, Construct, Plasmid Preparation, Fluorescence, Binding Assay, Mutagenesis, Western Blot